ChronicSildenafilImprovesErectileFunctionand Endothelium-dependent Cavernosal Relaxations in Rats: Lack oftachyphylaxis $
|
|
- Rudolf Melton
- 6 years ago
- Views:
Transcription
1 European Urology European Urology 47 (2005) ChronicSildenafilImprovesErectileFunctionand Endothelium-dependent Cavernosal Relaxations in Rats: Lack oftachyphylaxis $ Delphine Behr-Roussel a, Diane Gorny a, Katell Mevel a, Stéphanie Caisey a, Jacques Bernabé a, Gillian Burgess b, Chris Wayman b, Laurent Alexandre a, François Giuliano a,c, * a Pelvipharm, Domaine CNRS, 1 Avenue de la terrasse, Bâtiment 5, Gif sur Yvette, France b Pfizer Global Research and Development, Ramsgate Rd, Sandwich, Kent, CT13 9NJ, UK c Groupe de Recherche en Urologie, UPRES, EA 1602, University of Paris South, 63 rue du Général Leclerc, Le Kremlin Bicêtre, France Accepted 17 September 2004 Available online 7 October 2004 Abstract Objectives: Sildenafil is a widely-prescribed effective on-demand treatment of erectile dysfunction (ED). Chronic treatment with sildenafil could help patients with ED. Methods: The effects of an 8-week long treatment with sildenafil (60 mg/kg/d sc) in male Sprague Dawley rats were evaluated on electrically-elicited erectile responses in vivo before and after an acute injection of sildenafil (0.3 mg/ kg iv). In addition, endothelium-dependent and -independent relaxations of strips of corpus cavernosum in vitro were examined. All experiments were performed 36 hours after the last injection of sildenafil. Results: Endothelium-dependent relaxations of cavernosal strips to acetylcholine were enhanced after chronic treatment with sildenafil while relaxations to A23187 or sodium nitroprusside were unchanged. Frequencydependent erectile responses elicited by cavernous nerve stimulation were significantly improved. Moreover, the erectile responses to acute sildenafil were greater in chronically-treated rats with sildenafil. Conclusions: This is the first report providing experimental support for chronic dosing with sildenafil which could be of use for patients that are poor responders to on-demand treatment. Chronic sildenafil may regulate the transduction pathway leading to the activation of enos but has no effect on NO bioavailability or on the cgmp pathway, thereby eliminating a possible concern for tachyphylaxis. # 2004 Elsevier B.V. All rights reserved. Keywords: Erectile dysfunction; Sildenafil; PDE-5; Tachyphylaxis; Chronic administration; Corpus cavernosum; Endothelium 1.Introduction Upon sexual stimulation, penile erection, occurring in response to the activation of pro-erectile autonomic pathways, is greatly dependent on adequate inflow of blood to the erectile tissue and requires coordinated arterial endothelium-dependent vasodilatation and $ This work was supported by a grant from Pfizer and presented in abstract form at the last American Urological Association Annual Meeting (8 13 May 2004, San Fransisco, CA, USA). * Corresponding author. Tel ; fax: address: giuliano@cyber-sante.org (F. Giuliano). sinusoidal endothelium-dependent cavernosal smooth muscle relaxation [1]. NO is the principal peripheral pro-erectile neurotransmitter, released both by parasympathetic-nitrergic autonomic nerves and the sinusoidal endothelium to produce cgmp and relax cavernosal smooth muscle, and resulting ultimately in increased intracavernosal pressure (ICP) [2]. Sildenafil inhibits selectively type 5 cgmp-phosphodiesterase (PDE-5), resulting in an enhanced availability of cgmp in cavernosal tissues, relaxation of smooth muscle and increased blood flow into cavernosal spaces. Sildenafil was the first orally active drug to /$ see front matter # 2004 Elsevier B.V. All rights reserved. doi: /j.eururo
2 88 D. Behr-Roussel et al. / European Urology 47 (2005) treat patients with erectile dysfunction (ED) and has become the standard treatment for ED in more than 110 countries [3]. Although sildenafil has proven to be effective in treating ED, a report has suggested that its prolonged use may produce tachyphylaxis [4]. However, other clinical trials including more patients followed for longer periods of time have demonstrated only a small (less than 5%) patient dropout rate for lack of efficacy [5,6]. These low rates of withdrawal imply that men continued to be satisfied with sildenafil during longterm treatment. Furthermore, tachyphylaxis, in most pharmacological and human settings, does not occur with drugs that are used in an on-demand basis. Nonetheless, recent data has suggested that sildenafil could have additional and prolonged beneficial effects on endothelial function in diabetic patients if taken on a daily basis [7]. Furthermore, the use of chronic sildenafil could also improve nocturnal erectile activity, thus maintaining the morphodynamic integrity of smooth muscle cells within the corpora cavernosa [8]. Finally, despite broad clinical success of sildenafil in the treatment of ED, certain patients with severe ED i.e. Erectile Function Domain Scores between 1 and 10 [9] remain poor responders. Our hypothesis is that chronic treatment, far from inducing tachyphylaxis, could help salvage non-responders to sildenafil therapy. Thus, whether chronic treatment with sildenafil leads to tachyphylaxis is important to ascertain since it may have widespread implications, not only for sildenafil, but also for the other PDE-5 inhibitors, vardenafil and tadalafil if this is a class effect. The primary goal of this study was, therefore, to study the effects of chronic treatment with sildenafil on the erectile function in rats by (1) evaluating the effects of a chronic treatment with sildenafil on cavernosal tissue endothelial reactivity, and (2) studying their erectile responses elicited by electrical cavernous nerve stimulation under anaesthesia. Secondly, we investigated the sensitizing effect a chronic treatment with sildenafil on electrically-induced erectile responses before and after an acute administration of sildenafil in anaesthetized rats. 2.Methods 2.1. Animals Male Sprague-Dawley rats (Charles River, France, g, n = 44) were housed 7 days prior to the experiments with free access to food and water. All procedures were performed in accordance with the legislation on the Guide for the Care and Use of Laboratory Animals (NIH publication No , revised 1996) and Animal Care regulations in force in France as of Drugs and solutions Krebs bicarbonate solution of the following composition was used ((mmol l 1 ): NaCl 118.0; KCl 4.6; CaCl 2 2.5; KH 2 PO 4 1.2; MgSO 4 1.2; glucose 11.1; NaHCO ; HEPES, 20.85, ph ). The following drugs were used: phenylephrine, acetylcholine, A23187, sodium nitroprusside (Sigma, St Louis, USA), sildenafil mesylate (Pfizer, Sandwich, UK) Chronic treatment of rats Each experimental group received 20 mg/kg of sildenafil mesylate (or saline solution) via subcutaneous injection repeated three times a day (60 mg/kg/d in total) during 8 weeks. Body weight was recorded every day. Blood samples were collected before treatment, during the treatment period (bi-monthly, 6 8 h after a subcutaneous injection) and at the time of the in vivo experiments for the determination of free plasma concentrations of sildenafil (UK- 92,480) and its active metabolite (UK-103,320), as previously described [10]. All experiments were performed after a 36-h wash-out period Isometric tension studies in cavernosal strips Rats were terminally anaesthetized with sodium pentobarbital (50 mg/kg ip). The penis was carefully harvested, transferred into ice-cold Krebs bicarbonate solution and dissected. Cavernosal strips were placed in 5-ml organ baths filled with Krebs maintained at 37 8C, bubbled with 95% O 2-5%CO 2 and connected to a forcedisplacement transducer. Tissues were equilibrated for 60 min. Concentration-response curves to acetylcholine (ACh, 10 9 mol/l to 10 4 mol/l), A23187, a calcium ionophore (10 9 mol/l to mol/l) and sodium nitroprusside (SNP, 10 9 mol/l to 10 4 mol/l) were constructed on phenylephrine-induced pre-contracted tissues, as previously described [11] Erectile responses to cavernosal nerve stimulation in anaesthetized rats Erectile responses were elicited by electrical stimulation of the cavernous nerve in anaesthetized rats, as previously described [11]. Briefly, rats were anaesthetized with urethane (1.2 g/kg ip), tracheotomized and maintained at 37 8C. The carotid artery was catheterized to record arterial pressure and a 21-gauge needle was inserted into one of the corpus cavernosum of the penis to record ICP simultaneously via pressure transducers (Elcomatic 750, UK). The cavernous nerve was exposed at the lateral aspect of the prostate and mounted on a bipolar platinum electrode connected to an electrical stimulator (AMS 2100, Phymep, France). After stabilization, basal MAP was recorded. Electrical stimulations of the cavernous nerve (1 ms, 45 s, 6 V) at different frequencies (1, 2, 3, 4, 5 and 10 Hz) were performed in a randomized manner and repeated twice in order to establish frequency-response curves. Then, 4 minutes after an intravenous injection of sildenafil 0.3 mg/kg, electrical stimulations of the cavernous nerve at 1, 3 and 5 Hz were again performed before sacrifice of the rats with an overdose of urethane Calculations and statistical analysis Values are expressed as mean S.E. mean of n experiments. Tissue contractile responses were expressed as the absolute change in maximal developed tension (in g) normalized per gram tissue weight and relaxations as the percentage of change in phenylephrine-induced tone. Concentrations inducing 50% of the maximal effect were expressed as pd 2 values and calculated using GraphPad Prism. Erectile responses elicited by electrical stimulation were expressed as the ratio of DICP (mmhg)/map (mmhg) 100, with
3 D. Behr-Roussel et al. / European Urology 47 (2005) DICP, the difference between ICP in the flaccid state and ICP during the plateau phase of the erectile response and MAP, the mean arterial pressure during the plateau phase of the erectile response. This ratio accounts for the strong influence of the systemic blood pressure on the amplitude of ICP increase during the plateau phase [12]. Comparisons were performed using a twoway ANOVA statistical analysis followed by a Bonferroni s complementary analysis or Student s t-test where relevant. A p-value less than 0.05 was considered to be significant. 3.Results There was no statistical difference observed in body weight nor basal MAP between saline- or sildenafiltreated rats Functional in vitro studies Endothelial relaxation induced by ACh was significantly enhanced by 35% in rats treated chronically with sildenafil compared to untreated rats (n = 12, p < 0.01, two-way ANOVA) without a significant change in pd 2 ( vs , NS, Student s t-test). Conversely, relaxations elicited by A23187, a calcium ionophore, or by SNP were similar in tissues from chronically saline- or sildenafil-treated animals (Fig. 1) In vivo studies Mean trough plasma concentrations of free sildenafil (UK-92,480) and its active n-desmethyl metabolite, UK-103,320, during the 8-week long chronic treatment phase reached concentration above 30 nm throughout the study (Fig. 2). In untreated rats, there was no detectable levels of drug or metabolite. After a wash-out period of 36 h, concentrations of free sildenafil and its metabolite were still detected in the plasma (25 nm and 10 nm, respectively, Fig. 2). Chronic administration of sildenafil significantly enhanced frequency-dependent erectile responses in treated rats compared to untreated rats (i.e. maximal Fig. 1. Maximal relaxations induced by increasing concentrations of ACh (upper panel), A23187 (middle panel) or SNP (lower panel) in cavernosal strips from rats that have received saline (full circles) or sildenafil mesylate (20 mg/kg sc 3 /d, open circles) for 8 weeks. p < 0.01, Two-way ANOVA. Fig. 2. Mean plasma concentrations of free sildenafil (UK-92,480, upper panel) and its active n-desmethyl metabolite, UK-103,320 (lower panel) throughout the study.
4 90 D. Behr-Roussel et al. / European Urology 47 (2005) Fig. 3. Upper panel: Effect of a chronic treatment with saline (full circles) or sildenafil mesylate (20 mg/kg sc 3 /d, open circles) for 8 weeks on erectile responses elicited by cavernous nerve stimulation at increasing frequencies. p < 0.001, two-way ANOVA. Lower panel: Effect of an acute administration of sildenafil mesylate (0.3 mg/kg iv) on erectile responses elicited by cavernous nerve stimulation at increasing frequencies in rats that have received saline (hatched bars) or sildenafil mesylate (20 mg/ kg sc 3 /d, open bars) for 8 weeks. p < 0.01, two-way ANOVA; *p < 0.05, Bonferroni s complementary analysis. responses to 10 Hz-6Vof % vs %, p < 0.001, n = 10, two-way ANOVA, Fig. 3). The stimulation frequency required to produce 50% of the maximal erectile response following electrical stimulation was lower in the sildenafil-treated rats compared to saline rats ( versus Hz, respectively, p < 0.05, Student s t-test), thus indicating a shift to the left of the frequency-dependent erectile response curves. Most interestingly, rats treated with chronic sildenafil also gave a greater response (45% increase in the erectile response following electrical stimulation) toanacuteinjectionofsildenafilcomparedtoratsthathad received saline chronically (responses to 5 Hz-6V of % vs %, p < 0.05, n = 10, Bonferroni s complementary analysis, Fig. 3). 4.Discussion The main findings of these experiments are that a chronic treatment with sildenafil potentiates AChinduced endothelium-dependent cavernosal responses and enhances erectile responses in anaesthetized rats. A possible concern for tachyphylaxis with sildenafil has arisen with the suggestion that daily dosing with sildenafil may salvage poor responders to on-demand sildenafil therapy. Previous work with human cavernosal smooth muscle cells in culture had reported that tachyphylaxis could occur following repeated exposure to extremely high concentrations of sildenafil (25 mm) [13]. We addressed this issue in a different context using functional evaluation of endothelial and erectile responses after an exposure to sildenafil more closely related to those attained with treatment in humans [10] to investigate this concern. Overall rates of discontinuation from sildenafil treatment for ED have been reported to be very low in clinical trials [5,6]. Nonetheless, certain patients with severe ED remain poor responders. Indeed, the natural progression of the underlying ED causing reduction in neurotransmitter availability (i.e. endothelial dysfunction) with or without further reduction of vascular supply is nowadays considered as the main factor in any loss of efficacy of the treatment. Thus, in this study, we used normal rats to eliminate possible interference from a cardiovascular or metabolic-associated disease process on ED. In the present study, a chronic treatment with sildenafil potentiates ACh-induced endothelium-dependent cavernosal responses while A23187-induced and SNPinduced relaxant responses are not enhanced. This could indicate that either the muscarinic receptors or the transduction mechanisms leading to the activation of endothelial NOS are upregulated by a chronic treatment with sildenafil. Indeed, the activation of the PI3-kinase/Akt/eNOS phosphorylation cascade could be implicated [14,15], thus causing a more sustained NO release and relaxation [2]. The resulting increase in NO production could be still strictly-speaking calcium-dependent although the enzyme could be in an activated state at resting calcium levels [14,15]. This is of particular relevance since shear-stress induced NO-dependent relaxation, a more physiological stimulus of cavernosal smooth muscle endothelium-dependent relaxation, also relies on this signaling cascade to activate enos. In any case, it rules out an effect of chronic treatment with sildenafil on NO bioavailability, or on the subsequent guanylate cyclase pathway and smooth muscle responsiveness to NO, thereby eliminating concern about tachyphylaxis. Furthermore, erectile responses to electrical stimulation of the cavernous nerve are significantly enhanced following chronic exposure to sildenafil. Moreover, chronic treatment may actually sensitize the rats to an acute administration of sildenafil. It is to be noted that mean plasma concentrations of free
5 D. Behr-Roussel et al. / European Urology 47 (2005) sildenafil (UK-92,480) and its active n-desmethyl metabolite, UK-103,320 reached steady-state concentrations above 30 nm in rats during the treatment phase (free concentrations of 20 nm are known to give efficacy in man and 30 nm is equivalent to free plasma concentrations observed following a 100 mg dose of sildenafil in man [16]). However, the wash-out period that was selected (36 h), although sensible considering the half-life of sildenafil in rats (18 min) [10], was not sufficient to insure total elimination of sildenafil from the plasma of the chronically-treated rats. Although it is not possible to conclude that the enhancement of erectile responses induced by cavernous nerve stimulation was solely imputable to the chronic treatment in the in vivo experiments, the in vitro experiments support the concept of profound tissue modifications following chronic treatment with sildenafil. Indeed, in these experiments, tissue samples underwent extensive washings during the stabilization period, thus removing residual compound from the tissue. In spite of these extensive washings, cavernosal endotheliumdependent ACh-induced relaxations were significantly enhanced in tissue samples from chronically-treated rats. Thus, the modifications induced by a chronic treatment with sildenafil were still present although the compound had been most likely washed away. In conclusion, chronic treatment with sildenafil may actually exert beneficial effects on erectile function that go beyond those obtained from acute administration. If confirmed in humans, this could help salvage poor responders to sildenafil therapy. Furthermore, because of its effect on the potentiation of endothelium-dependent cavernosal relaxations, chronic treatment with sildenafil could be of particular benefit in patients with cardiovascular disease-related ED where cavernosal endothelial dysfunction occurs. It will thus be of great interest to test this concept in pathophysiological experimental animal models known to display this abnormality [11,17,18]. Moreover, further investigations are needed to determine whether this beneficial effect is specific to sildenafil or is a class effect associated with inhibition of PDE-5. Acknowledgements We thank Sophie Goyer for skilled help in data management. References [1] Andersson KE, Wagner G. Physiology of penile erection. Physiol Rev 1995;75: [2] Hurt KJ, Musicki B, Palese MA, Crone JK, Becker RE, Moriarity JL, et al. Akt-dependent phosphorylation of endothelial nitric-oxide synthase mediates penile erection. Proc Natl Acad Sci USA 2002;99: [3] Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998;338: [4] El Galley R, Rutland H, Talic R, Keane T, Clark H. Long-term efficacy of sildenafil and tachyphylaxis effect. J Urol 2001;166: [5] Carson CC, Burnett AL, Levine LA, Nehra A. The efficacy of sildenafil citrate (Viagra) in clinical populations: an update. Urology 2002;60: [6] Christiansen E, Guirguis WR, Cox D, Osterloh IH. Long-term efficacy and safety of oral Viagra (sildenafil citrate) in men with erectile dysfunction and the effect of randomised treatment withdrawal. Int J Impot Res 2000;12: [7] Desouza C, Parulkar A, Lumpkin D, Akers D, Fonseca VA. Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes. Diabetes Care 2002;25: [8] Montorsi F, Maga T, Strambi LF, Salonia A, Barbieri L, Scattoni V, et al. Sildenafil taken at bedtime significantly increases nocturnal erections: results of a placebo-controlled study. Urology 2000;56: [9] Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 1999;54: [10] Walker DK, Ackland MJ, James GC, Muirhead GJ, Rance DJ, Wastall P, et al. Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man. Xenobiotica 1999;29: [11] Behr-Roussel D, Chamiot-Clerc P, Bernabé J, Mevel K, Alexandre L, Giuliano F. Erectile dysfunction in spontaneously hypertensive rats: pathophysiological mechanisms. Am J Physiol Regul Integr Comp Physiol 2003;284:R [12] Giuliano F, Bernabé J, Jardin A, Rousseau JP. Antierectile role of the sympathetic nervous system in rats. J Urol 1993;150: [13] Lin G, Xin ZC, Lue TF, Lin CS. Up and down-regulation of phosphodiesterase-5 as related to tachyphylaxis and priapism. J Urol 2003;170:S15 8. [14] Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Aktdependent phosphorylation. Nature 1999;399: [15] Fleming I, Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 2003;284:1 12. [16] Nichols DJ, Muirhead GJ, Harness JA. Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality. Br J Clin Pharmacol 2002;53(Suppl 1):5S 12S. [17] Azadzoi KM, Goldstein I. Erectile dysfunction due to atherosclerotic vascular disease: the development of an animal model. J Urol 1992;147: [18] Cellek S, Rodrigo J, Lobos E, Fernandez P, Serrano J, Moncada S. ;. Br J Pharmacol 1999;128:
The effect of sildenafil on electrostimulation-induced erection in the rat model
(2002) 14, 251 255 ß 2002 Nature Publishing Group All rights reserved 0955-9930/02 $25.00 www.nature.com/ijir The effect of sildenafil on electrostimulation-induced erection in the rat model N Ueno 1,
More informationTopical application of a Rho-kinase inhibitor in rats causes penile erection
(2004) 16, 294 298 & 2004 Nature Publishing Group All rights reserved 0955-9930/04 $30.00 www.nature.com/ijir Topical application of a Rho-kinase inhibitor in rats causes penile erection Y Dai 1,2,3, K
More informationOnset and duration of action of sildena l citrate for the treatment of erectile dysfunction
Onset and duration of action of sildena l citrate for the treatment of erectile dysfunction Ian Eardley, 1 Peter Ellis, 2 Mitradev Boolell 2 & Maria Wulff 2 1 Department of Urology, St James University
More informationRelaxation responses of aortic rings from salt-loaded high calcium fed rats to potassium chloride, calcium chloride and magnesium sulphate
Pathophysiology 4 (1998) 275 280 Relaxation responses of aortic rings from salt-loaded high calcium fed rats to potassium chloride, calcium chloride and magnesium sulphate B.J. Adegunloye, O.A. Sofola
More informationNitric Oxide in the Penis: Scientific Discoveries and Clinical Applications
Nitric Oxide in the Penis: Scientific Discoveries and Clinical Applications Arthur L. (Bud) Burnett, M.D., M.B.A., F.A.C.S. Patrick C. Walsh Professor of Urology The James Buchanan Brady Urological Institute
More informationEfficacy of Sildenafil Citrate at 12 Hours after Dosing: Re-exploring thetherapeutic Window
European Urology European Urology 46 (2004) 357 361 Efficacy of Sildenafil Citrate at 12 Hours after Dosing: Re-exploring thetherapeutic Window Ignacio Moncada *, José Jara, David Subirá, Irene Castaño,
More informationfor ED and LUTS/BPH Pierre Sarkis, M.D. Assistant Professor Fellow of the European Board of Urology
Tadalafil 5 mg once daily for ED and LUTS/BPH Pierre Sarkis, M.D. Assistant Professor Fellow of the European Board of Urology Why this conference? Not promotional but educational The pharmacist regularly
More informationIC351 (tadalafil, Cialis): update on clinical experience
(2002) 14, Suppl 1, S57 S64 ß 2002 Nature Publishing Group All rights reserved 0955-9930/02 $25.00 www.nature.com/ijir IC351 (tadalafil, Cialis): update on clinical experience 1 * 1 Urological practice,
More informationDefined as the consistent inability to attain and maintain an erection adequate for sexual intercourse Usually qualified by being present for several
Defined as the consistent inability to attain and maintain an erection adequate for sexual intercourse Usually qualified by being present for several months and occurring at least half the time. Vinik
More informationPenile Rehabilitation After Radical Prostatectomy: Important Therapy or Wishful Thinking?
MANAGEMENT UPDATE Penile Rehabilitation After Radical Prostatectomy: Important Therapy or Wishful Thinking? Joseph E. Dall Era, MD, Jesse N. Mills, MD, Hari K. Koul, MD, Randall B. Meacham, MD Division
More informationCan Phosphodiesterase Type 5 Inhibitors Cure Erectile Dysfunction?
european urology 49 (2006) 979 986 available at www.sciencedirect.com journal homepage: www.europeanurology.com Review Sexual Medicine Can Phosphodiesterase Type 5 Inhibitors Cure Erectile Dysfunction?
More informationClinic for urology, pediatric urology and andrology. Penile diseases. Dr. Arne Hauptmann
Clinic for urology, pediatric urology and andrology JUSTUS- LIEBIG UNVERISTY GIESSEN Penile diseases Dr. Arne Hauptmann Clinic for urology, pediatric urology and andrology University Giessen und Marburg
More informationOral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction
(2000) 12, Suppl 1, S75±S80 ß 2000 Macmillan Publishers Ltd All rights reserved 0955-9930/00 $15.00 www.nature.com/ijir Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of
More informationOpinion: Yes. PDE-5 inhibitors should be used post radical prostatectomy as erection function rehabilitation?
Difference of opinion Vol. 43 (3): 385-389, May - June, 2017 doi: 10.1590/S1677-5538.IBJU.2017.03.03 PDE-5 inhibitors should be used post radical prostatectomy as erection function rehabilitation? Opinion:
More informationLONG-TERM EFFECT OF SILDENAFIL CITRATE ON ERECTILE DYSFUNCTION AFTER RADICAL PROSTATECTOMY: 3-YEAR FOLLOW-UP
ADULT UROLOGY LONG-TERM EFFECT OF SILDENAFIL CITRATE ON ERECTILE DYSFUNCTION AFTER RADICAL PROSTATECTOMY: 3-YEAR FOLLOW-UP RUPESH RAINA, MILTON M. LAKIN, ASHOK AGARWAL, RAKESH SHARMA, KUSH K. GOYAL, DROGO
More informationErection Capability Is Potentiated by Long-Term Sildenafil Treatment: Role of Blood Flow-Induced Endothelial Nitric-Oxide Synthase Phosphorylation
0026-895X/05/6801-226 232$20.00 MOLECULAR PHARMACOLOGY Vol. 68, No. 1 Copyright 2005 The American Society for Pharmacology and Experimental Therapeutics 10678/3040759 Mol Pharmacol 68:226 232, 2005 Printed
More informationRecovery of erectile function after nerve-sparing radical prostatectomy: improvement with nightly low-dose sildenafil
Sexual Medicine RECOVERY OF ERECTILE FUNCTION AFTER NERVE-SPARING RP WITH NIGHTLY LOW-DOSE SILDENAFIL BANNOWSKY et al. Associate Editor Michael G. Wyllie Editorial Board Ian Eardley, UK Jean Fourcroy,
More informationMMM. Topic The use of Tadalafil 5mg daily for the treatment of BPH-LUTS
Dr Tan & Partners MMM Vol. 1 No. 1 Morbidity & Mortality Meeting 14 th November 2014 Introduction Topic The use of Tadalafil 5mg daily for the treatment of BPH-LUTS Tadalafil 5mg daily is a well established
More informationRelaxation mechanisms of neferine on the rabbit corpus cavernosum tissue in vitro
Asian J Androl 2007; 9 (6): 795 800 DOI: 10.1111/j.1745-7262.2007.00321.x www.asiaandro.com. Original Article. Relaxation mechanisms of neferine on the rabbit corpus cavernosum tissue in vitro Jun Chen
More informationTadalafil: a novel treatment for erectile dysfunction
European Heart Journal Supplements (22) 4 (Supplement H), H24 H31 Tadalafil: a novel treatment for erectile dysfunction F. Giuliano 1 and L. Varanese 2 1 Department of Urology, AP-HP, Centre Hospitalier
More information/02/ /0 Vol. 168, , October 2002 THE JOURNAL OF UROLOGY
0022-5347/02/1684-1332/0 Vol. 168, 1332 1336, October 2002 THE JOURNAL OF UROLOGY Printed in U.S.A. Copyright 2002 by AMERICAN UROLOGICAL ASSOCIATION, INC. DOI: 10.1097/01.ju.0000028041.27703.da Original
More informationMALE SEXUAL DYSFUNCTION. Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara
MALE SEXUAL DYSFUNCTION Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara DEFINITION The inability to achieve a satisfactory sexual relationship May involve : - inadequacy
More informationGUIDELINES ON PRIAPISM
GUIDELINES ON PRIAPISM (Text update March 2015) A. Salonia, I. Eardley, F. Giuliano, I. Moncada, K. Hatzimouratidis Eur Urol 2014 Feb;65(2):480-9 Introduction Priapism is a pathological condition representing
More informationNovel nitric oxide signaling mechanisms regulate the erectile response
(2004) 16, S15 S19 & 2004 Nature Publishing Group All rights reserved 0955-9930/04 $30.00 www.nature.com/ijir Novel nitric oxide signaling mechanisms regulate the erectile response Department of Urology,
More informationManaging Erectile Dysfunction
Managing Erectile Dysfunction Lewis E. Harpster MD, FACS Urology of Central PA 4/23/16 1 Objectives 1. Review physiologic mechanism of erection 2. Discuss medical management of ED 3. Discuss surgical management
More informationDaily Treatment with Sildenafil Reverses Endothelial Dysfunction and Oxidative Stress in an Animal Model of Insulin Resistance
european urology 53 (2008) 1272 1281 available at www.sciencedirect.com journal homepage: www.europeanurology.com Sexual Medicine Daily Treatment with Sildenafil Reverses Endothelial Dysfunction and Oxidative
More informationErectile Dysfunction: A Primer for Primary Care Providers
Erectile Dysfunction: A Primer for Primary Care Providers Jeanne Martin, DNP, ANP-BC Objectives 1. Understand the definition, incidence and prevalence of Erectile Dysfunction in the U.S. 2. Understand
More informationPenile Rehabilitation after Radical Prostatectomy
Penile Rehabilitation after Radical Prostatectomy The PRO Position John P. Mulhall MD MSc FECSM FACS Director, Sexual & Reproductive Medicine Program Urology Service Memorial Sloan Kettering Cancer Center
More informationThe efficacy and safety of tadalafil: an update
Original Article C.C. CARSON et al. The efficacy and safety of tadalafil: an update C.C. CARSON, J. RAJFER, I. EARDLEY, S. CARRIER, J.S. DENNE, D.J. WALKER, W. SHEN and W.H. CORDELL Department of Surgery,
More informationPriapism. Medical Student case-based learning
Priapism Medical Student case-based learning A 45 year old man presents with an erection lasting over 5 hours. What are the two major subtypes of priapism? Types of Priapism Ischemic veno-occlusive or
More information, David Stultz, MD. Erectile Dysfunction. David Stultz, MD September 10, 2001
Erectile Dysfunction David Stultz, MD September 10, 2001 Case Presentation A 66 year old male presents to your office requesting Viagra. He states that for the past year he has had difficulty forming
More informationLight-controlled relaxation of the rat penile corpus cavernosum using NOBL-1, a novel nitric oxide releaser
Original Article - Basic and Translational Research ICUrology 216;57:215-22. http://dx.doi.org/1.4111/icu.216.57.3.215 pissn 2466-493 eissn 2466-54X Light-controlled relaxation of the rat penile corpus
More informationChronic Daily Administration of Vardenafil in Erectile Dysfunction Patients Has No Impact on Semen Parameters or on Sex Hormones Levels
Australian Journal of Basic and Applied Sciences, 2(3): 779-784, 2008 ISSN 1991-8178 Chronic Daily Administration of Vardenafil in Erectile Dysfunction Patients Has No Impact on Semen Parameters or on
More informationReactivity of the isolated perfused rat tail vascular bed
Brazilian Journal of Medical and Biological Research (1997) 30: 891-895 Perfused rat tail vascular bed ISSN 0100-879X 891 Reactivity of the isolated perfused rat tail vascular bed A.S. França, L.V. Rossoni,
More informationReview Article Penile Rehabilitation Therapy with PDE-V Inhibitors Following Radical Prostatectomy: Proceed with Caution
Advances in Urology Volume 2009, Article ID 852437, 4 pages doi:10.1155/2009/852437 Review Article Penile Rehabilitation Therapy with PDE-V Inhibitors Following Radical Prostatectomy: Proceed with Caution
More informationEFFICACY OF TADALAFIL FOR THE TREATMENT OF ERECTILE DYSFUNCTION AT 24 AND 36 HOURS AFTER DOSING: A RANDOMIZED CONTROLLED TRIAL
ADULT UROLOGY EFFICACY OF TADALAFIL FOR THE TREATMENT OF ERECTILE DYSFUNCTION AT 24 AND 36 HOURS AFTER DOSING: A RANDOMIZED CONTROLLED TRIAL HARTMUT PORST, HARIN PADMA-NATHAN, FRANÇOIS GIULIANO, GREG ANGLIN,
More informationDisclosure Slide. Dr Michael Gillman IMPOTENCE ERECTILE DIFFICULTIES. Do Men Really Care??? 15/10/2014 ASSESSMENT OF ERECTILE DYSFUNCTION
ASSESSMENT OF ERECTILE DYSFUNCTION Dr Michael Gillman St Andrews Hospital North St Specialist Suites Mater Hospital 3 rd Floor Mater Private Clinic Wesley Hospital Suite 5 Level 9 Evan Thomson Bld Cleveland-
More informationDiagnosis and management of sexual dysfunction. Dr Chris Simpson Consultant Psychiatrist
Diagnosis and management of sexual dysfunction Dr Chris Simpson Consultant Psychiatrist What are we talking about? Male Erectile dysfunction Premature ejaculation Delayed ejaculation Sexual aversion Paraphilia
More informationAssessment of Erectile and Ejaculatory Function after Penile Prosthesis Implantation
www.kjurology.org DOI:.4/kju.2.5.3.22 Sexual Dysfunction/Infertility Assessment of Erectile and Ejaculatory Function after Penile Prosthesis Implantation Jang Ho Bae, Phil Hyun Song, Hyun Tae Kim, Ki Hak
More informationThe New England Journal of Medicine
The New England Journal of Medicine Copyright, 199, by the Massachusetts Medical Society VOLUME 33 M AY 14, 199 NUMBER ORAL IN THE TREATMENT OF ERECTILE DYSFUNCTION IRWIN GOLDSTEIN, M.D., TOM F. LUE, M.D.,
More informationLONG-TERM INTRACAVERNOUS THERAPY RESPONDERS CAN POTENTIALLY SWITCH TO SILDENAFIL CITRATE AFTER RADICAL PROSTATECTOMY
ADULT UROLOGY LONG-TERM INTRACAVERNOUS THERAPY RESPONDERS CAN POTENTIALLY SWITCH TO SILDENAFIL CITRATE AFTER RADICAL PROSTATECTOMY RUPESH RAINA, MILTON M. LAKIN, ASHOK AGARWAL, SANDRA AUSMUNDSON, DROGO
More informationComment [DS1]: Why in quotes, because directly from the paper??
Spring 2014 undergraduate students note: This case was prepared by three undergraduate students in Chemistry and BME. It scored 49 out of 50 pts possible for the three students. The paper is longer than
More informationManaging the Patient with Erectile Dysfunction: What Would You Do?
Managing the Patient with Erectile Dysfunction: What Would You Do? Florida A & M University College of Pharmacy and Pharmaceutical Sciences 42 nd Annual Clinical Symposium Wayne A. Sampson, M.D. Cross
More informationSidney Glina Faculdade de Medicina do ABC Instituto H. Ellis Editor-in-Chief of the International Brazilian Journal of Urology
Sidney Glina Faculdade de Medicina do ABC Instituto H. Ellis Editor-in-Chief of the International Brazilian Journal of Urology (www.intbrazjurol.com.br) glinas@terra.com.br Conflict of Interest: In the
More informationGerald Brock Professor of Surgery University of Western Ontario
Treatment Induced Erectile Dysfunction Gerald Brock Professor of Surgery University of Western Ontario 1 1 2 Should you believe in Rehab? 3 3 Should you believe in Rehab? Avoidance Education related to
More informationDifferent hemodynamic responses by color Doppler ultrasonography studies between sildenafil non-responders and responders
DOI: 10.1111/j.1745-7262.2007.00227.x www.asiaandro.com. Clinical Experience. Different hemodynamic responses by color Doppler ultrasonography studies between sildenafil non-responders and responders Shih-Tsung
More informationAcceptance of and Discontinuation Rate from Erectile Dysfunction Oral Treatment in Patients following Bilateral Nerve-Sparing Radical Prostatectomy
european urology 53 (2008) 564 570 available at www.sciencedirect.com journal homepage: www.europeanurology.com Prostate Cancer Acceptance of and Discontinuation Rate from Erectile Dysfunction Oral Treatment
More informationEfficacy of Sildenafil Citrate intreatment of Erectile Dysfunction:EffectofType2Diabetes
European Urology European Urology 46 (2004) 503 509 Efficacy of Sildenafil Citrate intreatment of Erectile Dysfunction:EffectofType2Diabetes Ahmed I. El-Sakka a,b,* a Department of Urology, Suez Canal
More informationTestosterone and PDE5 inhibitors in the aging male
Testosterone and PDE5 inhibitors in the aging male Francesco Romanelli Department of Experimental Medicine Medical Pathophysiology, Food Science and Endocrinology Section Sapienza University of Rome 3005
More informationErectile Dysfunction (ED) Shawn McGee M.D. CentraCare Adult and Pediatric Urology January 30 th, 2016
Erectile Dysfunction (ED) Shawn McGee M.D. CentraCare Adult and Pediatric Urology January 30 th, 2016 Erectile dysfunction: The inability to attain or maintain penile erection sufficient for satisfactory
More informationMedicines Q&As. Date prepared: November 2016
Q&A 128.3 What is the rationale and evidence for the use of phosphodiesterase-5 inhibitors as supportive therapy to rehabilitate Erectile Function after nerve sparing radical prostatectomy? Summary Prepared
More informationERECTION MISDIRECTION: PENILE REHABILITATION & TREATMENTS FOR ERECTILE DYSFUNCTION. Gregory Harochaw Pharmacy Manager Tache Pharmacy (204)
ERECTION MISDIRECTION: PENILE REHABILITATION & TREATMENTS FOR ERECTILE DYSFUNCTION Gregory Harochaw Pharmacy Manager Tache Pharmacy (204) 233-3469 Nerve Function After careful prostatectomy where the erectile
More informationEvidence Review for Surrey Prescribing Clinical Network. Treatment: Oral and non-oral combination therapy for erectile dysfunction
Evidence Review for Surrey Prescribing Clinical Network Treatment: Oral and non-oral combination therapy for erectile dysfunction Prepared by: Linda Honey Topic Submitted by: Prescribing Clinical Network
More information/04/ /0 Reprinted from Vol. 172, , August 2004 THE JOURNAL OF UROLOGY
0022-5347/04/1722-0658/0 Reprinted from Vol. 172, 658 663, August 2004 THE JOURNAL OF UROLOGY Printed in U.S.A. Copyright 2004 by AMERICAN UROLOGICAL ASSOCIATION DOI: 10.1097/01.ju.0000132389.97804.d7
More informationIntracavernous administration of SIN-1 þ VIP in an in vivo rabbit model for erectile function
(2002) 14, 44 49 ß 2002 Nature Publishing Group All rights reserved 0955-9930/02 $25.00 www.nature.com/ijir Intracavernous administration of SIN-1 þ VIP in an in vivo rabbit model for erectile function
More informationASSESSMENT OF PREMATURE EJACULATION AND ERECTILE DYSFUNCTION
ASSESSMENT OF PREMATURE EJACULATION AND ERECTILE DYSFUNCTION Dr Michael Gillman St Andrews Hospital Wickham Terrace Spring Hill Mater Private Clinic, South Brisbane Shore St West Medical Centre, Cleveland
More informationInformation for Patients. Priapism. English
Information for Patients Priapism English Table of contents What is priapism?... 3 What causes priapism?... 3 Diagnosing priapism... 3 Treating priapism... 4 Conservative, first- and second-line treatments...
More informationPotentiation of Penile Tumescence by T-1032, a New Potent and Specific Phosphodiesterase Type V Inhibitor, in Dogs
0022-3565/00/2943-0870$03.00/0 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 294, No. 3 Copyright 2000 by The American Society for Pharmacology and Experimental Therapeutics 2623/843022
More informationSexual dysfunction in men with diabetes
Article Sexual dysfunction in men with diabetes Lesley Mills Citation: Mills L (2015) Sexual dysfunction in men with diabetes. Journal of Diabetes Nursing 19: 332 8 Article points 1. Sexual dysfunction
More informationThe use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction
(2002) 14, 245 250 ß 2002 Nature Publishing Group All rights reserved 0955-9930/02 $25.00 www.nature.com/ijir The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic
More informationLONG-TERM POTENCY AFTER IODINE-125 RADIOTHERAPY FOR PROSTATE CANCER AND ROLE OF SILDENAFIL CITRATE
ADULT UROLOGY CME ARTICLE LONG-TERM POTENCY AFTER IODINE-125 RADIOTHERAPY FOR PROSTATE CANCER AND ROLE OF SILDENAFIL CITRATE RUPESH RAINA, ASHOK AGARWAL, KUSH K. GOYAL, CHERYL JACKSON, JAMES ULCHAKER,
More informationBJUI. Study Type Diagnostic (case series) Level of Evidence 4 OBJECTIVE CONCLUSIONS
2008 The Authors. Journal compilation 2008 BJU International Sexual Medicine PARK et al. BJUI BJU INTERNATIONAL Why a combined intracavernosal injection with trimix and oral sildenafil is reliable therapy
More informationEndothelial and neuronal-derived nitric oxide mediated relaxation of corpus cavernosal smooth muscle in a rat, in vitro, model of erectile function
(2000) 12, 213±221 ß 2000 Macmillan Publishers Ltd All rights reserved 0955-9930/00 $15.00 www.nature.com/ijir Endothelial and neuronal-derived nitric oxide mediated relaxation of corpus cavernosal smooth
More informationEffects of plant extract neferine on cyclic adenosine monophosphate and cyclic guanosine monophosphate levels in rabbit corpus cavernosum in vitro
Asian J Androl 2008; 10 (2): 307 312 DOI: 10.1111/j.1745-7262.2008.00342.x www.asiaandro.com. Original Article. Effects of plant extract neferine on cyclic adenosine monophosphate and cyclic guanosine
More informationSYED TABREZ ALI Department of Physiology, Faculty of Medicine P.O. Box 7607, Umm-Al-Qura University, Makkah, Saudi Arabia
EFFECTIVENESS OF SILDENAFIL CITRATE (VIAGRA TM ) AND TADALAFIL (CIALIS TM ) ON SEXUAL RESPONSES IN SAUDI MEN WITH ERECTILE DYSFUNCTION IN ROUTINE CLINICAL PRACTICE SYED TABREZ ALI Department of Physiology,
More informationWITH ERECTILE DYSFUNCTION
Clinical Urology International Braz J Urol Vol. 29 (4): 320-326, July - August, 2003 Official Journal of the Brazilian Society of Urology OF PATIENTS WITH ERECTILE DYSFUNCTION JOAQUIM A. CLARO, SÉRGIO
More informationSponsored by. Schering. Sidney Glina
Sponsored by Schering Sidney Glina Testosterone and erectile dysfunction Sidney Glina Keywords Androgen Hormone replacement therapy Hypogonadism Impotence Testosterone Abstract The role of testosterone
More informationIntroduction. Original Article: Clinical Investigation. Lu Sun, 1,3 Fang-Li Peng, 2 Zhi-Ling Yu, 1 Cai-Ling Liu 1 and Jun Chen 3.
bs_bs_banner International Journal of Urology (2014) 21, 1263 1267 doi: 10.1111/iju.12564 Original Article: Clinical Investigation Combined sildenafil with vacuum erection device therapy in the management
More informationCanadian Undergraduate Urology Curriculum (CanUUC): Erectile Dysfunction
Canadian Undergraduate Urology Curriculum (CanUUC): Erectile Dysfunction Last reviewed July 2014 Objectives 1. Define erectile dysfunction 2. List and classify the risk factors for erectile dysfunction
More informationEffect of chronic hypoxia on penile erectile function in rats
Effect of chronic hypoxia on penile erectile function in rats D.P. Yu 1, X.H. Liu 2 and A.Y. Wei 3 1 Department of Urology, The First People s Hospital of Jining City in Shandong Province, Jining, Shandong,
More informationA Proposed Study of Hyperbaric Oxygen Therapy Following Radical Prostatectomy: Effects on Erectile Dysfunction
A Proposed Study of Hyperbaric Oxygen Therapy Following Radical Prostatectomy: Effects on Erectile Dysfunction Anthony J. Bella MD, FRCSC Division of Urology, Department of Surgery and Department of Neuroscience
More informationMinimal Clinically Important Differences in the Erectile Function Domain of the International Index of Erectile Function Scale
EUROPEAN UROLOGY 60 (2011) 1010 1016 available at www.sciencedirect.com journal homepage: www.europeanurology.com Platinum Priority Sexual Medicine Editorial by Andrea Salonia on pp. 1017 1019 of this
More informationImmediate penile prosthesis insertion after failed T shunt and snake maneuver in patient with prolonged priapism
Immediate penile prosthesis insertion after failed T shunt and snake maneuver in patient with prolonged priapism Evangelos Zacharakis PhD, FRCS, FECSM, FEAA Consultant Urological Surgeon St Peter s Anrology
More informationThe Role of Testosterone in the Sexual Function. Luiz Otavio Torres President Elect of ISSM Belo Horizonte - Brazil
The Role of Testosterone in the Sexual Function Luiz Otavio Torres President Elect of ISSM Belo Horizonte - Brazil Hormones and Sexual Function Paraventricular Nucleus Stimuli visual Sexual Desire Melatonine
More informationLong-term efficacy and compliance of intracorporeal (IC) injection for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis
(2003) 15, 318 322 & 2003 Nature Publishing Group All rights reserved 0955-9930/03 $25.00 www.nature.com/ijir Long-term efficacy and compliance of intracorporeal (IC) injection for erectile dysfunction
More informationProduct Introduction
Product Introduction 康達生命科學有限公司 Contek Life Science Co., Ltd. Red Algae Peptide Hydrolysate-EDpeptide The Next Generations of Erectile Dysfunction Cure Introduction of small peptides Erectile dysfunction
More informationMariya bought this for me (Zak) at Shaw s supermarket in Cambridge because she knew I would love it. How did she know? 2
1 Mariya bought this for me (Zak) at Shaw s supermarket in Cambridge because she knew I would love it. How did she know? 2 Notice the active ingredient: levmetamfetamine Another way to spell it: levo-methamphetamine
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,500 108,000 1.7 M Open access books available International authors and editors Downloads Our
More informationReversal by L-arginine of a dysfunctional arginine/nitric oxide pathway in the endothelium of the genetic diabetic BB rat
Diabetologia (1997) : 91 915 Springer-Verlag 1997 Reversal by L-arginine of a dysfunctional arginine/nitric oxide pathway in the endothelium of the genetic diabetic BB rat G.M. Pieper, W. Siebeneich, G.
More informationBEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE. Bulletin 169: Daily Tadalafil (Cialis ) for penile rehabilitation following radical prostactectomy
BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE September 2012 Review date: September 2014 Bulletin 169: Daily Tadalafil (Cialis ) for penile rehabilitation following radical prostactectomy JPC Recommendation:
More informationErectile Dysfunction in Hypertensive Rats Results from Impairment of the Relaxation Evoked by Neurogenic Carbon Monoxide and Nitric Oxide
253 Original Article Erectile Dysfunction in Hypertensive Rats Results from Impairment of the Relaxation Evoked by Neurogenic Carbon Monoxide and Nitric Oxide Masayuki USHIYAMA, Toshisuke MORITA, Tomoya
More informationERECTION HARDNESS: A UNIFYING FACTOR FOR DEFINING RESPONSE IN THE TREATMENT OF ERECTILE DYSFUNCTION
ERECTION HARDNESS: A UNIFYING FACTOR FOR DEFINING RESPONSE IN THE TREATMENT OF ERECTILE DYSFUNCTION JOHN P. MULHALL, LAURENCE A. LEVINE, and KLAUS-PETER JÜNEMANN ABSTRACT The extensive sildenafil citrate
More informationJan Farrell Nurse Consultant Urological Services Department of Urology Rotherham General Hospital NHS FT
Jan Farrell Nurse Consultant Urological Services Department of Urology Rotherham General Hospital NHS FT Aims of session To promote discussion / interaction Opportunity to discuss with peers Promote learning
More informationAbstract. Introduction. Vascular and cavernosal smooth muscle in the penis
RBMOnline - Vol 7. No 4. 456 461 Reproductive BioMedicine Online; www.rbmonline.com/article/994 on web 9 October 2003 Article Novel PDE5 inhibitors for the treatment of male erectile dysfunction Jas Kalsi
More informationI N T I M A C Y A N D S E X U A L I T Y I N L A T E R L I F E
I N T I M A C Y A N D S E X U A L I T Y I N L A T E R L I F E 2 0 1 6 DESPITE THE COMMON COMPLAINT, EACH PATIENT COMES AS AN INDIVIDUAL, WITH UNIQUE EXPECTATIONS My special interest Counseling patients
More informationERECTILE DYSFUNCTION DIAGNOSIS
ERECTILE DYSFUNCTION DIAGNOSIS Head of Andrology and Sexual Medicine Dep.of Urology and Nefrology Hospital Virgen del Rocío ANDROMEDI. Sexual Medicine SEVILLA. SPAIN General Secretary ESSM Natalio Cruz
More informationErectile dysfunction (ED) is one of the most
Low-Intensity Extracorporeal Shock Wave Therapy A Novel Effective Treatment for Erectile Dysfunction in Severe ED Patients Who Respond Poorly to PDE5 Inhibitor Therapyjsm_2498 1..6 1 Ilan Gruenwald, MD,
More informationMolecular Pharmacotherapeutic Targeting of PDE5 for Preservation of Penile Health
Journal of Andrology, Vol. 29, No. 1, January/February 2008 Copyright E American Society of Andrology Molecular Pharmacotherapeutic Targeting of PDE5 for Preservation of Penile Health Review ARTHUR L.
More information/03/ /0 Vol. 170, , July 2003 THE JOURNAL OF UROLOGY. Printed in U.S.A. Copyright 2003 by AMERICAN UROLOGICAL ASSOCIATION
0022-5347/03/1701-0159/0 Vol. 170, 159 163, July 2003 THE JOURNAL OF UROLOGY Printed in U.S.A. Copyright 2003 by AMERICAN UROLOGICAL ASSOCIATION DOI: 10.1097/01.ju.0000072524.82345.6d COMPARISON OF SATISFACTION
More informationSphingosine 1-Phosphate Induces Endothelial Nitric-Oxide Synthase Activation through Phosphorylation in Human Corpus Cavernosum
0022-3565/06/3162-703 708$20.00 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 316, No. 2 Copyright 2006 by The American Society for Pharmacology and Experimental Therapeutics 93419/3072529
More informationMANAGEMENT UPDATE , LLC MedReviews
MANAGEMENT UPDATE 2013 MedReviews, LLC rostate cancer is the most common cancer in men over the age of 50 years. 1 When patients undergo a radical prostatectomy (RP), there is a risk of postoperative erectile
More informationTreatment Strategy for Non-Responders to Tadalafil and Vardenafil: A Real-Life Study
european urology 50 (2006) 126 133 available at www.sciencedirect.com journal homepage: www.europeanurology.com Sexual Medicine Treatment Strategy for Non-Responders to Tadalafil and Vardenafil: A Real-Life
More informationMiscellaneous. The Relationship between Lipid Profile and Erectile Dysfunction MOHAMMADREZA NIKOOBAKHT*, MAZIAR POURKASMAEE, HAMIDREZA NASSEH
Urology Journal UNRC/IUA Vol. 2, No. 1, 40-44 Winter 2005 Printed in IRAN Miscellaneous The Relationship between Lipid Profile and Erectile Dysfunction MOHAMMADREZA NIKOOBAKHT*, MAZIAR POURKASMAEE, HAMIDREZA
More informationSildenafil citrate improves erectile function after castration in a rat model
Sildenafil citrate improves erectile function after castration in a rat model John P. Mulhall*, Nipun Verma, Serkan Deveci, Raanan Tal*, Keith Kobylarz and Alexander Müller* *Department of Urology, Memorial
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT VIAGRA 25 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 25 mg sildenafil as citrate.
More informationDifferential responses to endothelial dependent relaxation of the thoracic and abdominal aorta from male Sprague-Dawley rats
Niger. J. Physiol. Sci. 27(December 12) 117 122 www.njps.com.ng Differential responses to endothelial dependent relaxation of the thoracic and abdominal aorta from male Sprague-Dawley rats 1 Oloyo, Ahmed
More informationRationale for the Combination of PGE 1 and S-Nitrosoglutathione to Induce Relaxation of Human Penile Smooth Muscle 1
0022-3565/00/2952-0586$03.00/0 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 295, No. 2 Copyright 2000 by The American Society for Pharmacology and Experimental Therapeutics 2715/853843
More informationEndothelial Nitric Oxide Synthase Keeps Erection Regulatory Function Balance in the Penis
european urology 51 (2007) 1732 1740 available at www.sciencedirect.com journal homepage: www.europeanurology.com Sexual Medicine Endothelial Nitric Oxide Synthase Keeps Erection Regulatory Function Balance
More informationORIGINAL ARTICLE Vascular risk factors and erectile dysfunction in a cohort of healthy men
(2006) 18, 489 493 & 2006 Nature Publishing Group All rights reserved 0955-9930/06 $30.00 www.nature.com/ijir ORIGINAL ARTICLE in a cohort of healthy men A Ponholzer 1, C Temml 2, M Rauchenwald 1 and S
More informationERECTILE DYSFUNCTION. & Current Therapies. GP Conference, Rotorua 7-10 June 2012
ERECTILE DYSFUNCTION & Current Therapies GP Conference, Rotorua 7-10 June 2012 Jan Burns & Annie Woodsford Jan: EN, RCpN, BHSc, RPN (USA),MHSc, Member of the Sexual Medicine Society Urology Nurse Specialist
More information